Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: A case report and review of the literature

Cornea

Volumn 30, Issue 4, 2011, Pages 462-465

  García, Diana Pérez ^a   Alperte, Juan Ibáñez ^a   Cristóbal, José A ^a   Mateo Orobia, Antonio J ^a   Muro, Enrique Mínguez ^a   Valyi, Zsuzsanna ^a   Del Rio, Beatriz Jiménez ^a   Arnao, María Rojo ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b Hospital Luis Sanchez Bulnes   (Mexico)

Author keywords

Atopic keratoconjunctivitis; giant papillae; tacrolimus 0.03 ointment

Indexed keywords

CHLORPHENIRAMINE MALEATE; CYCLOSPORIN A; STEROID; TACROLIMUS;

ADULT; ARTICLE; ATOPIC KERATOCONJUNCTIVITIS; ATOPY; BIOMICROSCOPY; CASE REPORT; CLINICAL FEATURE; CONJUNCTIVAL HYPEREMIA; EPIPHORA; EYE PAIN; HUMAN; KERATITIS; MALE; PHOTOPHOBIA; PRIORITY JOURNAL; PRURITUS; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ADULT; CHRONIC DISEASE; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; TACROLIMUS; TREATMENT OUTCOME;

EID: 79952991138     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181d83875     Document Type: Article

References (14)

1. Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res. 2002;21:319-339. (Pubitemid 34614554)
2. Bonini S, Schiavone M, Bonini, et al. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunc-tivitis. Ophthalmology. 1997;104:849-853. (Pubitemid 27200885)
3. Almawi WY, Melemedjian OK. Clinical and mechanistic differences between FK-506 (tacrolimus) and cyclosporine A. NephrolDial Transplant. 2000;15:1916-1918.
4. Kymionis GD, Tsilimbaris M, Iliaki O, et al. Treatment of atopic eyelid disease using topical tacrolimus following corticosteroid discontinuation in a patient with open-angle glaucoma. Cornea. 2004;23:828-830. (Pubitemid 39447316)
5. Koo JY, Fleisher AB Jr, Abramovits W, et al. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients. JAm Acad Dermatol. 2005;53:S195-S205. (Pubitemid 40966766)
6. Hooks M. Tacrolimus, a new immunosuppressant: a review of the literature. Ann Pharmacother. 1994;28:501-511. (Pubitemid 24123768)
7. Attax-Fox L, Barkana Y, Iskhakov V, et al. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study. Curr Eye Res. 2008;33:545-549. (Pubitemid 351948486)
8. Vintanen HM, Reitamo S, Kari M, et al. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Acta Ophthalmol Scand. 2006;84:693-695. (Pubitemid 44317552)
9. Joseph MA, Kaufman HE, Insler M. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Cornea. 2005;24:417-420. (Pubitemid 40586629)
10. Vichyanond P, Tantimongkolsus C, Dumrongkigchaiporn P, et al. Vernal keratoconjunctivitis: results of a novel therapy with 0.1% topical ophthal-mic FK-506 ointment. JAllergy Clin Immunol. 2004;113:355-358. (Pubitemid 38210564)
11. Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, et al. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology. 2008;115:988-992.
12. Kymionis GD, Goldman D, Ide T, et al. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis. Cornea. 2008;27: 228-229. (Pubitemid 351158746)
13. Rikkers SM, Holland GN, Drayton GE. Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol. 2003;135:297-302. (Pubitemid 36279514)
14. Freeman AK, Serie J, VanVeldhuisen P. Tacrolimus ointment in the treatment of eyelid dermatitis. Cutis. 2004;73:267-271. (Pubitemid 38586569)